The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical Council (NPC)--invites you to join them for a webinar on April 8 at 12 pm ET.
During the one-hour webinar, CER Collaborative members will explain how to use the tools they developed to create greater uniformity and transparency when evaluating evidence for coverage and health care decision-making. Leading researchers also will discuss how these tools can help to ensure research studies are credible and relevant for decision-makers, as well as help participants:
- Understand compilations of good outcomes research practices for individual studies (e.g., prospective and retrospective observational studies, modeling approaches, indirect treatment comparisons);
- Learn how the CER Collaborative’s resources can benefit formulary decision-makers; and
- Discover how the tools can assist the pharmaceutical industry.
Speakers include:
- Marc Berger, MD, VP, real world data and analytics, Pfizer Inc
- Dan Allen, PharmD, clinical pharmacist consultant, OmedaRx
- Bernadette Eichelberger, PharmD, director, pharmacy affairs, Academy of Managed Care Pharmacy
- Jennifer Graff, PharmD, director, comparative effectiveness research, National Pharmaceutical Council
- Brian Sweet, MBA, executive director, U.S. payer & real world evidence, AstraZeneca (moderator)
Registration is available online, and there is no charge to participate in the webinar.